Experimental allergic encephalomyelitis (EAE) 1 is a clear example of an autoimmune disease mediated by class II-restricted T lymphocytes (1-5). Certain forms of EAE are characterized by relapsing paralysis, with histopathology revealing both perivascular lymphocytic cuffs and demyelination. Because of these features, chronic relapsing EAE is often cited as a model for the human disease multiple sclerosis (MS) (6). Further similarities exist between EAE and MS, including the presence of T helper cells in the inflammatory lesions (7,8), and the linkage of susceptibility for both EAE and MS to immune response genes (9, 10). With the capability for cloning antigen-specific T cells (1 1), it is now possible to analyze the precise cellular and immunogenetic mechanisms involved in EAE.Recently, it has been shown (12, 13) that the N-terminal 1-37 amino acid (aa) peptide of rat or guinea pig myelin basic protein (MBP) can induce EAE in PL/J (H-2 ") mice, while the C-terminal 89-169 aa peptide is encephalitogenic in SJL/ J (H-2 s) mice. The (PL/J × SJL/J)F1 [(PLSJ)FI] mice do not respond to MBP in a codominant manner. Instead, only the N-terminal peptide of MBP induces EAE in the (PLSJ)F1 mouse (12, 13).To characterize the T cells involved in the encephalitogenic response, MBPspecific T cell lines and clones have been isolated from (PLSJ)Ft mice after immunization with rat or bovine MBP. The separate determinants recognized by these clones have been investigated using peptides derived from MBP. In addition, the pattern of restriction to I-A or I-E class II molecules has been analyzed for each clone. With both the initial MBP-primed T cell lines and the L.